Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Citing concerns that “passion and prejudice” inflated the verdict, a judge on Tuesday slashed a record $134 million judgment awarded to three Nevada women by a jury that decided a drug made by the giant pharmaceutical company Wyeth caused their breast cancer. Washoe County District Court Judge Robert Perry granted the drug-maker’s motion to find the damages excessive. He ordered the award reduced to about $58 million – $23 million in compensatory and $35 million in punitive damages.

The judgment had been the largest award to date against the Madison, N.J.-based company, which faces about 5,300 similar lawsuits across the country in state and federal courts.

All involve the drugs Premarin, an estrogen replacement, and Prempro, a combination of estrogen and progestin. The drugs are prescribed to women to ease menopause symptoms.

Perry said the jury’s judgment of $35 million in compensatory damages and $99 million in punitive damages suggested the amounts were “the result of passion and prejudice.” The judge said he “does not lightly deviate from the jury’s verdict” after telling lawyers last week that he had been “considering this issue for a long time.”

“The court believes that this reduction in damages adequately compensates plaintiffs for the serious consequences which the jury found to have been caused by defendant, while also serving to punish defendant and deter others from similar conduct,” he wrote.

Wyeth lawyer Dan Webb had argued the jury verdict in October was “an extreme aberration” – 30 times greater than juries have awarded in four similar cases.

“It’s an injustice,” he said.

Jurors had awarded Jeraldine Scofield, 74, of Fallon; Arlene Rowatt, 67, of Incline Village; and Pamela Forrester, 65, of Yerington a combined $35 million for medical expenses and physical and emotional pain and suffering. The same panel then awarded the women $99 million in punitive damages.

Perry’s new ruling awards Scofield $7.3 million in compensatory damages and $12 million in punitive damages; Rowatt $7.6 million in compensatory damages and $10 million in punitive damages; and Forrester $8 million in compensatory damages and $13 million in punitive damages.

Zoe Littlepage, a lawyer for the women, had argued the jurors’ award was “very reasonable” given they “found this company caused these three women to get breast cancer.”

“But for taking this drug, they would not have gotten breast cancer,” she said.

Littlepage said the punitive award was “an insignificant amount of Wyeth’s net worth” – less than 1 percent of its $14.65 billion.

Perry said the women had offered “very limited evidence and argument in support of compensatory damages,” limited primarily to past medical bills. But he said the punitive damages were a different matter.

“There was substantial evidence from which the jury could conclude that Wyeth knew that its product could cause breast cancer, that it intentionally failed to conduct adequate tests, that it financed and manipulated scientific studies and sponsored articles in professional and scientific journals that deliberately minimized the risk of cancer while over-promoting certain benefits and citing others which it knew to be unsubstantiated,” Perry wrote.

“The evidence also supported the conclusion that Wyeth intentionally made similar misstatements and misleading assertions in its marketing to physicians and its advertising directed to the public,” the judge said.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 1 article* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.